You are here

  • Home
  • Archive
  • Volume 9, Issue 6
  • Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

Article metrics

Article menu

Download PDFPDF

XML
Urology
Protocol
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

 

Online download statistics by month:

Online download statistics by month: June 2019 to April 2024

AbstractFullPdf
Jun 201967967466
Jul 201912711742
Aug 2019555114
Oct 2019645917
Nov 2019565318
Dec 2019555216
Jan 202050418
Feb 202038389
Mar 202010210019
May 2020353524
Jun 2020373513
Jul 2020181726
Aug 202021209
Sep 2020242316
Oct 2020262616
Nov 2020393814
Dec 2020262510
Jan 2021141011
Feb 202122186
Mar 2021212110
Apr 202121207
May 2021191813
Jun 202124258
Jul 2021606022
Aug 2021484523
Sep 2021453020
Oct 2021393845
Nov 2021303118
Dec 2021454714
Jan 202228257
Feb 2022282110
Mar 2022292614
Apr 2022262211
May 2022181714
Jun 202223219
Jul 202219177
Aug 2022201810
Sep 2022221812
Oct 2022111111
Nov 202217177
Dec 202216165
Jan 202321197
Feb 202318166
Mar 2023161611
Apr 202318145
May 202312118
Jun 202325259
Jul 2023191911
Aug 202315144
Sep 202323205
Oct 202331251
Nov 202326256
Dec 2023473817
Jan 2024323211
Feb 2024464412
Mar 2024373853
Apr 2024212311
Total25042375828